HerbMate

Herb comparison

Andrographis (Andrographis paniculata) vs Astragalus (Astragalus membranaceus)

Both plants are listed as traditional remedies for 1 of the same condition, which is why they are easy to confuse. Their descriptions and full safety notes are below, free.

Andrographis (Andrographis paniculata) plant

Andrographis (Andrographis paniculata)

Astragalus (Astragalus membranaceus) plant

Astragalus (Astragalus membranaceus)

About
Andrographis, commonly known as Green Chiretta or King of Bitters, is an upright annual herb reaching approximately 3 feet in height. Native to India and cultivated throughout northern regions of India and China, this bitter medicinal plant has been valued in Ayurvedic and traditional Chinese medicine for centuries. MSK notes that it has been studied mostly for colds, flu and upper respiratory infections. The plant thrives on plains and in forest undergrowth, where its spotted pale brown or purple flowers and long seed capsules distinguish it from other medicinal herbs.
Astragalus (Astragalus membranaceus), known in China as huang qi, is a perennial reaching about 16 in (40 cm), with hairy stems and compound leaves composed of multiple leaflet pairs. Its root has been used for centuries in traditional Chinese medicine, often with other herbs, and NCCIH says it is promoted to improve the response of the immune system. NCCIH says there is not enough reliable evidence to know whether astragalus helps any health condition.
Safety & precautions
Pregnancy & Breastfeeding: Avoid, because andrographis may affect fertility and uterine contractions. High doses can cause nausea, vomiting, and gastrointestinal upset. Medicines: MSK notes laboratory signs of reduced platelet clumping (although a rat study found no interaction with warfarin), possible added blood-pressure lowering, possible interference with some chemotherapy drugs, and a possible rise in side effects from aminophylline. Whether andrographis meaningfully blocks drug-processing enzymes is uncertain: MSK cites laboratory inhibition of CYP1A2, CYP2C9 and CYP3A4, while a 2015 review judged the data too limited to call it an inhibitor. Professional supervision is recommended for long-term use.
Skin Disorders & Acute Illness: It is generally recommended not to use astragalus during active skin disorders or acute infections. Individual Variation: NCCIH says astragalus may be safe by mouth but has not had a thorough safety evaluation, and that people with autoimmune diseases should avoid it. Use it with care if there are any underlying health issues, and it may need to be avoided in certain inflammatory skin conditions.

Safety text above is printed in full and is never abbreviated. For each plant’s complete precautions, drug and food interactions and preparation notes, open its own page - both are free.

Conditions that list both